SUBSCRIBE
SUBSCRIBE

Phase II

Policy
Biopharma Update on the Novel Coronavirus: September 14
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 14, 2020.
September 14, 2020
 · 
3 min read
 · 
BioSpace Editorial Staff
BioCapital
Clinical Catch-Up: September 7-11
It was a busy week for clinical trial updates. Here’s a look.
September 11, 2020
 · 
10 min read
 · 
Mark Terry
Policy
Biopharma Update on the Novel Coronavirus: September 11
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 11, 2020.
September 10, 2020
 · 
2 min read
 · 
BioSpace Editorial Staff
Drug Development
Preclinical Data Supports Efficacy for Pfizer, BioNTech Phase II/III COVID-19 Vaccine
Preclinical data for Pfizer and BioNTech’s Phase II/III COVID-19 mRNA vaccine candidate generated BNT162b2 strong anti-viral effects against an infectious SARS-CoV-2 challenge.
September 9, 2020
 · 
3 min read
 · 
Alex Keown
Policy
Biopharma Update on the Novel Coronavirus: September 9
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 9, 2020.
September 8, 2020
 · 
4 min read
 · 
BioSpace Editorial Staff
Use of AI in medical field.
Drug Development
AI in Medical Field for Clinical Trials Increase, Refining Endpoints, Quantifying Pain, & More
Ai in medical field is helping the researchers at clinical stage research by increasing the efficiency, refining endpoints and quantifying pain, and much more.
September 4, 2020
 · 
4 min read
 · 
Gail Dutton
Drug Development
Clinical Catch-Up: August 31-September 4
It was a busy week for both COVID-19-related clinical trial news and the rest of the industry. Here’s a look.
September 4, 2020
 · 
9 min read
 · 
Mark Terry
Drug Development
Biopharma Update on the Novel Coronavirus: September 4
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 4, 2020.
September 3, 2020
 · 
3 min read
 · 
BioSpace Editorial Staff
Jana Shea/Shutterstock
Drug Development
Amylyx’ ALS Drug Shows Promise in Phase II/III Clinical Trial
Amylyx Pharmaceuticals published data from its Phase II/III CENTAUR clinical trial evaluating AMX0035 in amyotrophic lateral sclerosis (ALS) which met its primary endpoint.
September 3, 2020
 · 
3 min read
 · 
Mark Terry
Courtesy of Willy Barton/Getty Images
Business
Sanofi, GSK Move COVID-19 Vaccine Candidate Into the Clinic, Expect Data by December
Months after forging a development partnership for a COVID-19 vaccine, GlaxoSmithKline and Sanofi are moving their adjuvanted vaccine candidate into the clinic.
September 3, 2020
 · 
2 min read
 · 
Alex Keown
Load More
PRESS RELEASES
Drug Development
Possible New Hope for Metastatic Cancer Patients: Food and Drug Administration Grants Approval for Clinical Trials For Lamassu’s Groundbreaking Cancer Treatment Protocol
April 11, 2024
 · 
2 min read
Drug Development
Boundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene Amplifications
April 11, 2024
 · 
7 min read
Drug Development
Enlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra™ In Patients With Sepsis
April 11, 2024
 · 
9 min read
Drug Development
Algiax Pharmaceuticals Expands Phase 2a Study with Lead Candidate AP-325 in Chronic Neuropathic Pain with 12 New Clinical Sites in Belgium and France
April 11, 2024
 · 
3 min read
Drug Development
Allay Therapeutics’ Phase 2B Clinical Study Supports Ability of ATX101 To Deliver Four Weeks of Sustained Post-surgical Pain Relief
April 11, 2024
 · 
7 min read
Drug Development
Amylyx Pharmaceuticals Announces Interim Data From Ongoing Phase 2 HELIOS Clinical Trial Demonstrating Improvements in Pancreatic Function and Glycemic Control with AMX0035 in People with Wolfram Syndrome
April 10, 2024
 · 
10 min read
Business
Gabather Joins Forces with the Centre for Neuropsychiatric Schizophrenia Research in Denmark to Conduct a Clinical Phase II Study with GT-002
April 10, 2024
 · 
5 min read
Drug Development
EpiEndo reports Phase 2A results for lead asset, EP395, in COPD
April 10, 2024
 · 
4 min read
Drug Development
Medicenna Presents Updated Results of Single Agent MDNA11 Anti-tumor Activity from Dose Escalation and Ongoing Dose Expansion of the Phase 1/2 ABILITY-1 Study
April 10, 2024
 · 
9 min read
Drug Development
ALX Oncology Reports Encouraging Clinical Data of Evorpacept in Combination with Standard-of-Care in an Ongoing Phase 1/2 Clinical Trial in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (“R/R B-NHL”)
April 9, 2024
 · 
8 min read
Drug Development
Notable Labs Presents the Design Plan for the PPMP-Enabled Phase 2 Trial with Volasertib for Relapsed/Refractory AML at AACR 2024
April 9, 2024
 · 
8 min read
Drug Development
Medicenna Presents Updated Results of Single Agent MDNA11 Anti-tumor Activity from Dose Escalation and Ongoing Dose Expansion of the Phase 1/2 ABILITY-1 Study at the 2024 Annual Meeting of the American Association for Cancer Research (AACR)
April 9, 2024
 · 
9 min read
Drug Development
Fusion Pharmaceuticals Announces Presentation of Interim Data from the Phase 2 TATCIST Clinical Trial Evaluating FPI-2265 at the AACR Annual Meeting 2024
April 9, 2024
 · 
8 min read
Drug Development
RAPT Therapeutics Announces Promising Results from Phase 2 Trial of Tivumecirnon in Combination with Anti-PD-1 Immunotherapy in CPI-Experienced Head and Neck Cancer Patients
April 9, 2024
 · 
6 min read
Drug Development
Galectin Therapeutics Reports the Positive Outcome of the Fifth Data and Safety Monitoring Board Meeting for NAVIGATE Phase 2b/3 Study of Belapectin in Patients with Cirrhotic Portal Hypertension Caused by MASH
April 9, 2024
 · 
9 min read
Drug Development
Biophytis launches OBA phase 2 clinical study in obesity with BIO101 (20-hydroxyecdysone)
April 8, 2024
 · 
5 min read
Drug Development
KRAZATI (adagrasib) in Combination with Cetuximab Demonstrates Clinically Meaningful Activity as a Targeted Treatment Option for Patients with Previously Treated KRAS G12C-Mutated Locally Advanced or Metastatic Colorectal Cancer (CRC)
April 8, 2024
 · 
12 min read
Drug Development
NRx Pharmaceuticals (NASDAQ:NRXP) Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression
April 8, 2024
 · 
7 min read
Drug Development
Entera Bio Announces Publication of Oral PTH(1-34) Peptide Tablets (EB613) Phase 2 Trial Data in the Journal of Bone and Mineral Research
April 8, 2024
 · 
6 min read
Drug Development
American College of Cardiology Presentation Highlights Promising Results Showing Potential to Reduce Coronary Inflammation with Abcentra’s Orticumab
April 8, 2024
 · 
5 min read
Load More